Abstract Rationale: Cannabis-based medicinal products (CBMPs) have been identified as novel therapeutics for generalised anxiety disorder (GAD) based on pre-clinical…
Abstract Introduction: : There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze…
Abstract Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment…
Abstract Background: In the UK, legislation and regulations governing medical cannabis and over the counter cannabidiol (CBD) wellness products have…
Abstract Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to…
Abstract Cannabis‐based medicinal products (CBMPs) are an emerging therapeutic option in the management of primary chronic pain, using the role…
Abstract Aim: Cannabis‐based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high‐quality randomized controlled trials. The…
Abstract Background: End colostomy rates following colorectal resection vary across institutions in high‐income settings, being influenced by patient, disease, surgeon…
Abstract Background: Appendicitis is the most common abdominal surgical emergency worldwide. Differences between high- and low-income settings in the availability…